NO20084525L - Farmasoytiske sammensetninger inneholdende NMB0606-protein - Google Patents

Farmasoytiske sammensetninger inneholdende NMB0606-protein

Info

Publication number
NO20084525L
NO20084525L NO20084525A NO20084525A NO20084525L NO 20084525 L NO20084525 L NO 20084525L NO 20084525 A NO20084525 A NO 20084525A NO 20084525 A NO20084525 A NO 20084525A NO 20084525 L NO20084525 L NO 20084525L
Authority
NO
Norway
Prior art keywords
composition
present
nmb0606 protein
nmb0606
protein
Prior art date
Application number
NO20084525A
Other languages
English (en)
Norwegian (no)
Inventor
Sonia Gonzalez Blanco
Rolando Pajon Feyt
Yasser Perera Negrin
Gretel Sardinas Garcia
Darien Garcia Diaz
Karem Cobas Acosta
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of NO20084525L publication Critical patent/NO20084525L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20084525A 2006-03-31 2008-10-28 Farmasoytiske sammensetninger inneholdende NMB0606-protein NO20084525L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060075A CU23575A1 (es) 2006-03-31 2006-03-31 Composición farmacéutica que comprende la proteína nmb0606
PCT/CU2007/000013 WO2007112703A2 (es) 2006-03-31 2007-03-29 Composición farmacéutica que comprende la proteína nmb0606

Publications (1)

Publication Number Publication Date
NO20084525L true NO20084525L (no) 2008-11-28

Family

ID=38535626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084525A NO20084525L (no) 2006-03-31 2008-10-28 Farmasoytiske sammensetninger inneholdende NMB0606-protein

Country Status (13)

Country Link
US (1) US20100129387A1 (pt)
EP (1) EP2011509A2 (pt)
KR (1) KR20080108576A (pt)
CN (1) CN101448518A (pt)
AR (1) AR060797A1 (pt)
AU (1) AU2007234214A1 (pt)
BR (1) BRPI0709922A2 (pt)
CA (1) CA2647465A1 (pt)
CU (1) CU23575A1 (pt)
MX (1) MX2008012665A (pt)
NO (1) NO20084525L (pt)
WO (1) WO2007112703A2 (pt)
ZA (1) ZA200808768B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109890413B (zh) 2016-09-02 2024-04-16 赛诺菲巴斯德股份有限公司 脑膜炎奈瑟氏菌疫苗
US12599655B2 (en) * 2019-08-01 2026-04-14 Trustees Of Tufts College Neisseria gonorrhoeae vaccine compositions and methods of selecting antigens
CN119792505A (zh) * 2023-10-10 2025-04-11 康希诺生物股份公司 一种抗脑膜炎球菌的免疫组合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1179072A2 (en) * 1999-05-19 2002-02-13 Chiron S.P.A. Combination neisserial compositions
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
CU23236A1 (es) * 2003-12-03 2007-09-26 Ct Ingenieria Genetica Biotech PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P

Also Published As

Publication number Publication date
AR060797A1 (es) 2008-07-16
AU2007234214A1 (en) 2007-10-11
KR20080108576A (ko) 2008-12-15
BRPI0709922A2 (pt) 2011-07-26
CA2647465A1 (en) 2007-10-11
WO2007112703A2 (es) 2007-10-11
MX2008012665A (es) 2008-10-13
CU23575A1 (es) 2010-09-30
WO2007112703A3 (es) 2008-04-24
CN101448518A (zh) 2009-06-03
US20100129387A1 (en) 2010-05-27
EP2011509A2 (en) 2009-01-07
ZA200808768B (en) 2009-07-29

Similar Documents

Publication Publication Date Title
Olsen et al. Porphyromonas gingivalis disturbs host–commensal homeostasis by changing complement function
Rajapaksha et al. Update on new aspects of the renin-angiotensin system in hepatic fibrosis and portal hypertension: implications for novel therapeutic options
Durbin et al. Next-generation dengue vaccines: novel strategies currently under development
Cashman et al. Enhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporation
WO2008079372A3 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
CA2818969A1 (en) Improved n-terminal capping modules for designed ankyrin repeat proteins
AU2009326524A8 (en) Use of Flt3 ligand for strengthening immune responses in RNA immunization
CO7010783A2 (es) Proteína naglu humana recombinante y usos de la misma
WO2011110655A3 (en) Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease
NO20064584L (no) Tetrahydropyridoindolderivater
Riccardo et al. Neutralization determinants on poxviruses
CY1113693T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι για τον εμβολιασμο κατα της διαχυτης καντιντιασης και αλλων μολυσματικων παραγοντων
Ok et al. Candida infection associated with salivary gland—a narrative review
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
NO20062044L (no) Piscirickettsia salmonis-antigener og anvendelse derav
Tonolo et al. Antimicrobial and anti-inflammatory bioactive peptides: Their role in potential therapeutic applications for periodontitis—A narrative review
ATE520708T1 (de) Immunogenetische hiv-1 multi-klade, multivalente konstrukte und deren verwendung
Chai et al. Brief Comparison of Novel Influenza Vaccine Design Strategies
Xue et al. Immunomodulatory effects of gut microbiota on vaccine efficacy against respiratory pathogens
WO2010039924A3 (en) Th1 vaccination priming for active immunotheraphy
NO20084524L (no) Farmasoytisk sammensetning inneholdende NMB0938-protein
BRPI0818957B8 (pt) gene isolado, vetor de expressão, célula hospedeira geneticamente modificada e método para preparação de uma macromolécula imunogênica
WO2007112703A3 (es) Composición farmacéutica que comprende la proteína nmb0606
BR112015013625A2 (pt) adjuvante de vacinação, preparação e vacinas contendo o mesmo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application